Assessing Multiple Critical Quality Attributes of Monoclonal Antibody and Comparability Assessments

November 6, 2020
Agilent

Discover how LC–MS peptide mapping can be used to characterize and quantify different monoclonal antibody (mAb) critical quality attributes (CQAs).